Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

75.0%

-11.6% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 4

1(16.7%)

6Total

N/A(5)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04205500Not ApplicableActive Not Recruiting

Treatment With Specific Carbohydrate Diet in Children With Juvenile Idiopathic Arthritis

Role: collaborator

NCT04928170Active Not Recruiting

The Halland Osteoarthritis Cohort

Role: collaborator

NCT05815381Completed

Autoimmune Mechanisms in Fibromyalgia

Role: collaborator

NCT02022566Not ApplicableCompleted

Effect of Structured Info and Adapted Exercise in OA

Role: collaborator

NCT01992770Not ApplicableTerminated

A Stepped-care Model of Tailored Behavioural Medicine Pain Intervention in Primary Care

Role: collaborator

NCT01270087Phase 4Completed

The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study.

Role: collaborator

NCT00803491Not ApplicableUnknown

Health Related Quality of Life After a Self-promoting Learning Program for People With Rheumatic Diseases

Role: collaborator

NCT01071447Not ApplicableUnknown

Nurse-led Clinic for Patients With Rheumatic Diseases and Biological Treatment

Role: collaborator

All 8 trials loaded